Momentus Inc. is thrilled to reveal a new registered direct offering of 4,624,280 shares of common stock at a price...
Purple Biotech (NASDAQ: PPBT) announced today their quarterly losses of $(0.19) per share, in line with what analysts had predicted....
Analysts are bullish on Avadel Pharmaceuticals (NASDAQ: AVDL) after the company reported strong fourth-quarter revenue results. The new average price...
The latest data from March 5, 2024, reveals that the France Services Purchasing Managers Index (PMI) for February stood at...
On March 5, 2024, analyst Maria Ripps from Canaccord Genuity reaffirmed a Hold rating for Viant Technology (NASDAQ:DSP) and increased...
Gain Therapeutics has recently shared groundbreaking data on the potential of GT-02287 to halt the progression of Parkinson's disease by...
CASI Pharmaceuticals announced exciting progress on March 5, 2024, with the release of favorable interim Phase 1 findings for BI-1206...
On March 5, 2024, Alnylam and Roche announced the launch of the KARDIA-3 Phase 2 trial. This study will assess...
Myers Industries has experienced a notable surge of 13% in its stock price since announcing better-than-expected Q4 adjusted EPS results...
On March 5, 2024, analyst Linda Bolton Weiser from DA Davidson reiterated her positive outlook on WD-40 (NASDAQ: WDFC), maintaining...
